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Abstract
Objective: This study investigated whether endothelial dysfunction occurs in mesenteric arteries of apoE-deficient mice and determined
the role of endothelin (ET)-1, which is increased in human atherosclerosis, using an orally active endothelin ET receptor antagonist.A
Methods: ApoE-deficient and C57BL/6J control mice were fed for 30 weeks with normal chow or high-fat Western-type diet alone or in
combination with darusentan (LU135252; 50 mg/kg/day). Vasomotor reactivity of isolated small mesenteric arteries (I.D. 200–250 mm)
was studied in vitro under perfused and pressurized conditions. Results: In both mouse strains, about one fourth of the endothelium-
dependent relaxant response to acetylcholine was insensitive to inhibition by L-NAME and indomethacin. In mesenteric arteries of
apoE-deficient mice on Western-type diet, increased intima-media thickness and levels of endothelin-1 protein were observed. In addition,
NO-mediated endothelium-dependent relaxation to acetylcholine was reduced without affecting L-NAME/indomethacin insensitive
relaxation and contractions to endothelin-1 and serotonin were enhanced. Treatment with darusentan normalized vascular structure,
NO-mediated relaxation to acetylcholine and contractions to endothelin-1 and serotonin without affecting blood pressure or plasma
cholesterol levels. Conclusions: Severe hypercholesterolemia in apoE-deficient mice is associated with attenuation of NO-mediated
relaxation to acetylcholine and increased vascular endothelin-1 content. Chronic ET receptor blockade may provide a new therapeuticA
approach to improve NO-mediated endothelium-dependent vasomotion in small arteries.  2002 Elsevier Science B.V. All rights
reserved.
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1. Introduction ET -receptors. In hypercholesterolemia an elevated plasmaA
ET-1 concentration and enhanced coronary artery tissue
The vascular endothelium is a source of vasoactive ET-1 immunoreactivity were found [7,8].
substances such as nitric oxide (NO) [1] as well as Nitric oxide (NO) is a potent vasodilator and is formed
endothelin-1 (ET-1) [2] that modulate vascular smooth from L-arginine by endothelial NO synthase [1]. NO as
muscle tone and proliferation. Endothelin (ET)-1 is a well as prostacyclin inhibit ET-1 production [9] and
potent vasoconstrictor peptide [2] and its synthesis is furthermore, reduce ET-1 induced vasoconstriction in
stimulated by vasoactive factors implicated in vascular smooth muscle cells of small arteries [10,11].
atherogenesis [3]. ET-1 mediates contraction, cell prolifer- This indicates that NO protects small arteries against
ation [4,5], and vascular growth [6] via activation of contractions to ET-1 under physiological conditions. In
hypercholesterolemia, a major risk factor predisposing to
atherosclerosis, endothelial dysfunction is present before
* ¨ ¨Corresponding author. University Hospital Zurich, Ramistrasse 100 structural vascular changes occurs [12]. In addition, in
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endothelial dysfunction are present while intramyocardial flow-rate of 50 ml /min was aerated continuously with 95%
coronary arteries exhibit only impairment of endothelium- O –5% CO gas and kept at 378C. The proximal and distal2 2
dependent vasodilation [13–16]. ends of the vessels were mounted and sutured onto two
It is unknown whether endothelial dysfunction occur in small glass microcannulas. The assembly was positioned in
mesenteric arteries of apoE-deficient mice, which develop the vessel chamber and the perfusion pressure was set at
spontaneous hypercholesterolemia and aortic atherosclero- 30 mmHg. In pilot studies, this was found to be optimal
sis that can be accelerated by a lipid-rich, Western-type diet for contraction to norepinephrine as assessed by repeated
[17,18]. Using a selective, orally active antagonist for ET exposures at various perfusions pressures (15–105 mmHg)A
receptors, we investigated the role of ET-1 in small arteries using a transducer (Living Systems Instrumentation) con-
in this mouse model of human atherosclerosis. nected to the afferent cannula. The intraluminal flow-rate
was maintained at 0.2–0.4 ml /min. The perfusion chamber
was positioned on the stage of an inverted microscope
2. Methods (Nikon, TSM-F, Japan) with a video camera (Burle
Lancaster, PA, USA). The amplified image was transmitted
2.1. Animals and blood pressure to a monitor and a video dimension analyzer (V91, Living
Systems Instrumentation), allowing for measurements and
Male C57BL/6J (control) mice and homozygous apoE- recording of lumen diameter and wall thickness.
Tm1Unc129deficient mice (C57BL/6J-ApoE ) were obtained
at the age of 4–5 weeks from The Jackson Laboratory (Bar
2.4. Experimental protocolsHarbor, ME, USA). Housing facilities and all experimental
protocols were approved by the local authorities for animal
Arteries were equilibrated for 60 min and perfused¨research (Kommission fur Tierversuche des Kantons
intraluminally with Krebs solution containing 1% BSA.¨Zurich, Switzerland). To accelerate the development of
Resting lumen diameter was recorded during perfusionspontaneous atherosclerotic lesions [19], control and apoE-
with Krebs solution circulating from the reservoir. Be-deficient mice were fed a Western-type fat diet for 30
tween each protocol, the system was washed several timesweeks (0.15% cholesterol and 42% of milk fat by weight,
with Krebs solution and equilibrated for 30 min. Contrac-TD88137, Harlan Teklad, Madison, WI, USA) with or
210 25tile responses to norepinephrine (10 –10 mol / l),without the ET receptor antagonist darusentan (50 mg/A 210 25 211 28serotonin (10 –10 mol / l) and ET-1 (10 –3310kg/day). In a separate protocol, apoE-deficient mice
mol / l) were obtained. Endothelium-dependent relaxationsreceived normal chow diet with or without darusentan (50
29 24to acetylcholine (10 –10 mol / l) after 30 min ofmg/kg/day) for 30 weeks. Darusentan was mixed in
preincubation with or without inhibitor of NO formationpowdered form to the diet and dosed as previously
v 24N -nitro-L-arginine methyl ester (L-NAME; 10 mol / l)described [20,21]. Systolic blood pressure and heart rate
25or indomathacin (10 mol / l) alone or in combination ofwere measured in conscious mice by a tail-cuff method
both were obtained after stabilization of half-maximalusing a custom-made pulse transducer (Model LE 5000,
precontraction of mesenteric arteries with norepinephrine.Letica, Barcelona, Spain).
For endothelium-independent relaxations, sodium nitro-
210 25prusside (10 –3310 mol / l) was used.2.2. Tissue harvesting
The mice were anesthetized (thiopental, 50 mg/kg body 2.5. Plasma cholesterol levels
weight, i.p.) and sacrificed. A segment of the first branch
of the mesenteric artery (closest to ileum; diameter: 200– Blood samples were obtained through puncture of the
250 mm) was isolated and placed in cold (48C) modified right ventricle. Blood was immediately transferred to a
Krebs–Ringer bicarbonate solution (in mmol / l: NaCl tube containing EDTA and centrifuged at 48C for 10 min.
118.6; KCl 4.7; CaCl 2.5; MgSO 1.2; KH PO 1.2;2 4 2 4 Plasma was separated immediately at 48C and kept at2
NaHCO 25.1; EDTA 0.026; glucose 10.1). Mesenteric3 808C until assayed. Plasma LDL and HDL cholesterol
arteries were dissected free from connective tissue under a were determined using a colorimetric-based assay on a
microscope (Leica Wild M3C, Heerbrugg, Switzerland) Cobas Mira Plus autoanalyzer (Roche Diagnostics, Basel,
and cut into rings of 4–5 mm in length. Switzerland).
2.3. Vascular function experimental set-up
2.6. Vascular ET-1 Protein Levels
Isolated mesenteric arteries were transferred to vessel
chambers (Living Systems Instrumentation, Burlington, Remaining mesenteric arterial tissue (n54–8 per group)
VT, USA), filled with Krebs–Ringer bicarbonate solution. was dissected free, blotted dry, frozen in liquid nitrogen
The solutions circulating from a 250 ml reservoir at a and kept at 2808C until assayed. Frozen tissue was
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crushed and homogenized as described [6]. Eluates were 3. Results
dried in a speed-vac and reconstituted in working assay
buffer for the RIA. ET-1 was measured by RIA and the 3.1. Mice characteristics
peptide was identified by reverse-phase HPLC and related
to tissue weight [21]. ApoE-deficient mice were normotensive and systolic
blood pressure and heart rate did not differ between
darusentan-treated apoE-deficient and control mice (Table
2.7. Drugs 1). Body weight was increased in Western-diet fed apoE-
deficient mice as compared with normal chow diet (P,
Acetylcholine hydrochloride, L-norepinephrine bitartrate, 0.05, Table 1) and was further increased in control mice on
sodium nitroprusside dihydrate, 5-hydroxytryptamine high-fat diet (P,0.05, Table 1). Heart weight was aug-
(serotonin), indomethacin and L-NAME were from Sigma mented in apoE-deficient mice on Western-type diet (P,
(St. Louis, MO, USA) and ET-1 was from Novabiochem 0.05; Table 1). However, heart weight-to-body weight ratio
¨(Laufelfingen, Switzerland). Darusentan (LU135252), the was unchanged in apoE-deficient mice on Western-type
active (1)-isomer of LU127043, a non-peptide, selective diet as compared with normal chow diet (Table 1).
ET receptor antagonist was a gift from Knoll, Ludwigs- Treatment with ET receptor antagonist had no effect onA A
hafen, Germany. these parameters in all groups of treated mice (Table 1).
Plasma total cholesterol and LDL-cholesterol concen-
trations were elevated in apoE-deficient mice on normal
2.8. Data analysis diet as compared with C57BL/6J mice (P,0.05; Table 1).
The Western-type diet further increased plasma cholesterol
Sensitivity to different drugs was expressed as negative and LDL (P,0.05), but HDL was reduced (P,0.05; Table
logarithm of the concentration causing half-maximal relax- 1). Concomitant treatment with the ET receptor antago-A
ation or contraction (pD value). In addition, maximal nist had no effect on plasma cholesterol and LDL in2
contraction or relaxation (expressed as percentage of the apoE-deficient mice (Table 1) but increased HDL choles-
decrease in the basal intraluminal diameter or of the terol levels in C57BL/6J mice (P,0.05; Table 1).
increase in intraluminal diameter from the diameter ob-
tained after precontraction, respectively) were determined 3.2. Vascular structure
for each individual concentration–response curve by non-
linear regression analysis type sigmoid logistic using In mesenteric arteries, lumen diameter did not differ in

MATLAB software as described elsewhere [20,22]. CSA apoE-deficient and C57BL/6J mice (Table 2). Wall thick-
was calculated as follows [23,24]: (p /4)?[(I.D.12? ness and CSA were slightly increased only in apoE-
2 2(intima1media)] 2(I.D.) . Results are given as deficient mice on Western-type fat-diet (P,0.05; Table 2)
mean6S.E.M. In all experiments, n equals the number of and were prevented by concomitant treatment with
mice. For multiple comparisons, results were analyzed darusentan (P,0.05).
with ANOVA followed by Bonferroni’s correction. Pear-
son’s correlation coefficient was calculated by linear 3.3. Tissue ET-1 Levels
regression analysis. A P value ,0.05 was considered
significant. Tissue ET-1 content was increased in mesenteric arteries
Table 1
Characteristics of apoE-deficient and C57BL/6J control mice after 30 weeks treatment
Parameters C57BL/6J C57BL/6J1 ApoE ApoE1 ApoE ApoE1
darusentan darusentan darusentan
Diet WC WC NC NC WC WC
SBP (mmHg) ND 12762 12462 13062 12862 12761
Heart rate (beats /min) ND 488615 529617 49965 48368 51269
† †Body weight (g) 5061 4961 3261 3462 4463* 4062*
† †Heart weight (mg) 14164 13564 14063 13766 19066* 19564*
Heart /body weight (mg/g) 2.860.3 2.860.2 4.360.1* 4.160.3* 4.360.3* 4.960.2*
† †Total cholesterol (mmol / l) 3.660.4 5.960.3 7.660.5* 8.760.3* 18.862.6* 16.260.6*
† †LDL (mmol / l) 0.660.2 1.060.2 6.460.7* 6.960.8* 17.362.4* 15.360.6*
† †HDL (mmol / l) 2.760.2 4.860.3* 2.060.9 2.960.3 0.460.1* 0.360.1*
ApoE, apolipoprotein E deficient mice; C57BL/6J, control wild-type mice; darusentan, ET receptor antagonist; NC, normal chow diet; WC,A
Western-type chow diet; SBP, systolic blood pressure; ND, not determined. Data are means6S.E.M. of 5–9 mice.
*, P,0.05 vs. C57BL/6J control mice (ANOVA1Bonferroni).
†, P,0.05 vs. apoE-deficient mice on normal diet (ANOVA1Bonferroni).
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Table 2
Morphological characteristics of mesenteric arteries from apoE-deficient and wild-type mice measured in perfused and pressurized conditions
Parameters C57BL/6J C57BL/6J1 ApoE ApoE1 ApoE ApoE1
darusentan darusentan darusentan
Diet WC WC NC NC WC WC
Lumen diameter (mm) 22264 23567 21967 22869 21765 22666
† [Intima1media thickness (mm) 18.260.2 17.460.5 17.760.3 17.061.2 20.960.7* 16.860.4
3 2 † [Intima1media CSA (310 mm ) 14.360.2 13.960.6 13.260.5 13.060.6 15.660.6* 12.960.5
ApoE, apolipoprotein E-deficient mice; C57BL/6J, control wild-type mice; darusentan, ET receptor antagonist; NC, normal chow diet; WC,A
Western-type chow diet; CSA, cross-sectional area. Data are means6S.E.M. of 6–10 mice.
*, P,0.05 vs. C57BL/6J mice
†, P,0.05 vs. apoE-deficient group on normal chow diet
[, P,0.05 vs. apoE-deficient group on western-type chow diet (ANOVA1Bonferroni).
of apoE-deficient mice on Western-type diet as compared treated with and without darusentan (P,0.05 vs. without
with apoE-deficient mice on normal diet or C57BL/6J pretreatment; n55–7; Fig. 2C and D). Preincubation with
mice (P,0.05; Fig. 1). Darusentan prevented the increase indomethacin in the presence or absence of L-NAME did
in tissue ET-1 levels in apoE-deficient mice to a greater not affect acetylcholine-induced relaxations (data not
degree as compared with C57BL/6J mice on Western-type shown).
diet (n58, P,0.05, Fig. 1). Darusentan did not signifi- Chronic treatment with darusentan, increased the L-
cantly affect vascular ET-1 levels in apoE-deficient mice NAME-sensitive portion of the response in apoE-deficient
on normal diet (n54). mice on Western-type diet (P,0.05; n513; Fig. 2A).
Maximal responses were inversely correlated with tissue
3.4. Endothelial function ET-1 level in apoE-deficient mice on Western-type diet
(r520.77; P,0.005; n512) but not in C57BL/6J mice
Acetylcholine-induced relaxation was endothelium-de- (P50.95; n513; NS).
pendent. The relaxations were impaired in apoE-deficient Sensitivity but not maximal responses of endothelium-
mice as compared to control mice on Western-type diet independent relaxations to sodium nitroprusside were
(P,0.05 vs. C57BL/6J; Fig. 2A; n59). In contrast, the slightly lower in arteries from apoE-deficient mice as
relaxations were unaltered in apoE-deficient mice fed compared to controls (P,0.05 vs. C57BL/6J, Fig. 3A) and
normal diet (Fig. 2B; n510). Incubation with L-NAME was increased after darusentan (P,0.05 vs. apoE-deficient
alone reduced maximal responses to acetylcholine to a mice; Fig. 3A; n55–9), without affecting the maximal
comparable degree in apoE-deficient and C57BL/6J mice response. In C57BL/6J mice on Western-type diet or
apoE-deficient mice fed normal diet, no differences within
treatment groups were observed (Fig. 3A and B).
3.5. Vascular contractility
Maximal contractions to ET-1 were unaffected by
hypercholesterolemia, but the sensitivity of contractions to
ET-1 was slightly increased in apoE-deficient mice on
Western-type diet as compared with control mice (P,0.05;
n54; Fig. 4); this shift was normalized by darusentan
(P,0.05; n54; Fig. 4A). Concomitant treatment with
darusentan had no effect on contractions to ET-1 in
C57BL/6J mice on western-type diet or in apoE-deficient
mice on normal diet (Fig. 4B).
Maximal contractions to serotonin were markedly higher
in mesenteric arteries of apoE-deficient mice as compared
to controls fed Western-type diet (P,0.05; Fig. 5A). The
Fig. 1. Tissue concentrations of ET-1 in small mesenteric arteries of supersensitivity to serotonin was completely blocked by
apoE-deficient and C57BL/6J mice after 30 weeks treatment with chronic treatment with darusentan (P,0.05; n55–7; Fig.
Western type diet alone or in combination with the ET receptorA 5A).
antagonist darusentan (n54–8). For comparison, the results of normal fed
Contractions to norepinephrine were similar in apoE-apoE-deficient mice with or without darusentan are shown. *, P,0.05 vs.
† deficient mice and C57BL/6J mice fed Western-type diet.all other groups; , P,0.05 vs. apoE-deficient mice on Western-type diet;
[, P,0.05 vs. C57BL/6J mice (ANOVA1Bonferroni). Concomitant treatment with darusentan did not affect this
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Fig. 2. Endothelium-dependent relaxations to acetylcholine in small mesenteric arteries of apoE-deficient and control mice after 30 weeks treatment with
Western-type diet (A and C) and normal diet (B and D) alone or in combination with the ET receptor antagonist darusentan. Please note that relaxations toA
acetylcholine were reduced to the same extent in all groups in the presence of L-NAME (C and D). Results are shown as mean6S.E.M. (n55–13 per
group) and relaxations are expressed as percent of the increase in intraluminal diameter of the precontraction to norepinephrine.
response in apoE-deficient mice (Fig. 5B; n55–7 per (apoE) gene provide a new model of human atherosclero-
group). sis. These mice develop spontaneous hypercholesterolemia
and aortic atherosclerosis [17–19]. Heart rate and blood
pressure were comparable between apoE-deficient and
4. Discussion control mice on Western-type diet, but a significant de-
crease in body weight was found, while heart weight
This present study demonstrates that in small arteries of significantly increased. This is in line with the recent report
apoE-deficient mice fed Western-type diet tissue ET-1 by Hartley et al. [25]. Interestingly, our study showed that
content was elevated and was associated with increase in heart weight-to-body weight ratio was increased in apoE-
wall thickness and impairment of endothelium-dependent deficient mice on normal diet and this increase was
relaxation to acetylcholine. Chronic blockade of ET unaffected by Western-type diet. In addition, treatmentA
receptors with darusentan normalized NO-mediated portion with darusentan had no effect on these parameters in
of the endothelium-dependent relaxation to acetylcholine control and apoE-deficient mice irrespective of diet sug-
and reduced increased ET-1 production and vascular gesting that ET-1 does not play a major role to these
reactivity to ET-1 without affecting systolic blood pressure phenotypic alterations in apoE-deficient mice.
or cholesterol levels. An impaired endothelium-dependent relaxation in re-
Mice homozygous for the inactivated apolipoprotein E sponse to acetylcholine has been observed in the aorta
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Fig. 4. Concentration-dependent contractions to ET-1 in small mesenteric
Fig. 3. Endothelium-independent relaxations to the nitric oxide donor arteries of apoE-deficient and control mice after 30 weeks treatment with
sodium nitroprusside in small mesenteric arteries of apoE-deficient and Western-type diet (A) and normal diet (B) alone or in combination with
control mice after 30 weeks treatment with Western-type diet (A) and the ET receptor antagonist darusentan. Results are shown asA
normal diet (B) alone or in combination with the ET receptor antagonistA mean6S.E.M. (n54–7 per group) and contractions are expressed as
darusentan. Results are shown as mean6S.E.M. (n55–9 per group) and percent decrease of basal intraluminal diameter.
relaxations are expressed as percent of the increase in intraluminal
diameter of the precontraction to norepinephrine.
deficient mice on Western-type diet. In contrast to the aorta
[26–29] and in coronary arteries of genetically altered [26,29], relaxation to acetylcholine in mesenteric arteries
hyperlipidemic mice [30]. Interestingly, although athero- was inhibited only in part by L-NAME. The remaining
sclerosis primarily affects conduit arteries, endothelium- portion of the response was not further attenuated by
dependent relaxations are impaired not only in large indomethacin, suggesting that an endothelium-dependent
arteries but also in small arteries of atherosclerotic animals factor distinct from NO mediate part of relaxations to
and humans. In cremasteric vessels of cholesterol-fed acetylcholine in mouse mesenteric arteries. Atherosclerosis
rabbit cholinergic arteriolar vasodilation is defective [31]. had no effect on the L-NAME/indomethacin-insensitive
In coronary arteries, hypercholesterolemia is associated portion of the response, contrasting a previous study that
with impaired endothelium-dependent relaxations to the reported an augmentation of L-NAME/indomethacin-resis-
agonists serotonin, bradykinin and histamine [13–16] tant relaxations to acetylcholine in renal arteries of hy-
indicating that the pathophysiological consequences of percholesterolemic rabbits [32]. The discrepancy between
atherosclerosis may extend into small arteries also in these findings may be related to species differences and/or
humans. In our study, endothelium-dependent relaxations anatomic heterogeneity of vascular function. Furthermore,
to acetylcholine were reduced in small arteries of apoE- endothelium-dependent relaxations to acetylcholine were
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clude up-regulation of endothelial NO synthase protein, as
has been reported after chronic ET blockade in hy-A
percholesterolemic pigs [33,34]. In addition, the improve-
ment in endothelium-dependent relaxations also appears to
be related to an improved sensitivity of vascular smooth
muscle cells to NO, as illustrated by the results obtained
with the NO donor SNP.
ET-1 synthesis is stimulated by vasoactive factors and
cytokines implicated in hypercholesterolemia [3]. ET-1
also stimulates cell proliferation and acts as a co-mitogen
for vascular smooth muscle cells with other growth factors
[6,35], suggesting that ET-1 contribute to structural
changes through activation of multiple pathways. Impor-
tantly, ET-1 induces vascular hypertrophy is independent
of systolic blood pressure [6,21] and in addition, ETA
receptors promote the early inflammatory phase of athero-
sclerosis [36]. In our study, vascular ET-1 peptide content
and contractions to ET-1 were increased in small mesen-
teric arteries of apoE-deficient mice as compared with
control animals on Western-type diet. Increased contrac-
tions to ET-1 may be explained by the activation of signal
transduction pathways of ET-receptors. In addition, we
previously have shown that ET receptor density in apoE-A
deficient mice aortas was increased [26]. The impairment
of relaxation to acetylcholine was inversely related to
vascular tissue ET-1 peptide content. Indeed, in apoE-
deficient mice on normal diet neither endothelial dysfunc-
tion nor elevated tissue ET-1 content was found, despite a
slight increase in plasma cholesterol levels. These observa-
tions strongly support a role for local ET-1 as an early
participant in hypercholesterolemia and marker for endo-
thelial dysfunction in animals and humans [7,8,33].
Interestingly, the ET receptor antagonist darusentanA
markedly reduced tissue ET-1 levels and prevent structural
Fig. 5. Concentration-dependent contractions to serotonin (A) and norepi- changes in small mesenteric arteries, indicating that endog-
nephrine (B) in small mesenteric arteries of apoE-deficient mice as
enous ET-1 contributes to endothelial dysfunction. As nocompared with control C57BL/6J mice on Western-type diet. Results are
effects on blood pressure or plasma cholesterol wereshown as mean6S.E.M. (n55–9 per group) and contractions are ex-
observed, the local effects of ET-1 appear to be in-pressed as percent decrease of basal intraluminal diameter.
dependent of these risk factors. This is in line with the
most recent study showing that blockade of ET receptors
unaffected in the presence of indomethacin suggesting that facilitates the maintenance of vasodilation despite high
endothelium-derived prostanoids do not play a major role insulin concentrations [37]. In addition, darusentan treat-
in endothelial dysfunction. This is further confirmed by a ment increased plasma HDL levels in control mice but not
recent study showing that no change in cyclic adenosine in apoE-deficient mice on Western-type diet again sug-
monophosphate occurred in the aorta of apoE-deficient gesting that improvement of endothelial dysfunction in
mice [29]. apoE-deficient mice by darusentan treatment was due to
Interestingly, chronic treatment with ET receptor an- the decreased local ET-1 production rather than increasedA
tagonist darusentan normalized impaired endothelium-de- production of plasma HDL. The reason for HDL increase
pendent and -independent relaxations in small mesenteric by darusentan in control mice is unknown and remains to
arteries. However, only the L-NAME-sensitive portion of be determined.
the response to acetylcholine was increased indicating that Enhanced vasoconstriction to serotonin, which is an
the improvement of vascular reactivity was due to in- important factor aggravating ischemia in patients with
creased bioactivity of NO. In line with these observations, coronary artery disease, is present in animals and patients
we recently reported that plasma nitrate levels, an indicator with hypercholesterolemia and atherosclerosis [38–41]. In
of NO activity in vivo, are increased in darusentan-treated coronary arteries of apoE-deficient mice, fed a high
apoE-deficient mice [26]. Possible mechanisms may in- cholesterol diet, was associated with a reduction of endo-
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[2] Yanagisawa M, Kurihara H, Kimura S et al. A novel potentthelium-dependent relaxation to serotonin [30]. We here
vasoconstrictor peptide produced by vascular endothelial cells.demonstrate that in addition to impaired endothelium-
Nature 1988;332:411–415.dependent relaxation in small mesenteric arteries, the
[3] Miyauchi T, Masaki T. Pathophysiology of endothelin in the
contractions to serotonin were enhanced while contractions cardiovascular system. Annu Rev Physiol 1999;61:391–415.
to norepinephrine remained unaffected in apoE-deficient [4] Alberts GF, Peifley KA, Johns A, Kleha JF, Winkles JA. Constitu-
tive endothelin-1 overexpression promotes smooth muscle cellmice compared to control mice on Western-type diet. This
proliferation via an external autocrine loop. J Biol Chemis confirmed by a recent study showing that deletion of
1994;269:10112–10118.eNOS gene in mice is associated with enhanced contrac-
[5] Komuro I, Kurihara H, Sugiyama T, Yoshizumi M, Takaku F,tion to serotonin [42]. On the other hand, in isolated
Yazaki Y. Endothelin stimulates c-fos and c-myc expression and
human arteries sub-threshold concentrations of ET-1 proliferation of vascular smooth muscle cells. FEBS Lett
potentiate contractions to serotonin [43]. Thus, increased 1988;238:249–252.
¨[6] Moreau P, d’Uscio LV, Shaw S, Takase H, Barton M, Luscher TF.tissue ET-1 and endothelial dysfunction in mesenteric
Angiotensin II increases tissue endothelin and induces vasculararteries may selectively augment serotonin-mediated vas-
hypertrophy: reversal by ET -receptor antagonist. CirculationAoconstriction. Most interestingly, enhanced vasoconstric-
1997;96:1593–1597.tion was prevented by chronic ET receptor blockade,A [7] Lerman A, Webster MW, Chesebro JH et al. Circulating and tissue
suggesting a role for ET receptors and/or local ET-1A endothelin immunoreactivity in hypercholesterolemic pigs. Circula-
tissue levels on serotonin-mediated vasoconstriction. tion 1993;88:2923–2928.
[8] Lerman A, Holmes Jr. DR, Bell MR, Garratt KN, Nishimura RA,Improvement of vascular function and the reduction of
Burnett Jr. JC. Endothelin in coronary endothelial dysfunction andwall thickness after chronic ET receptor blockade wasA
early atherosclerosis in humans. Circulation 1995;92:2426–2431.associated with decreased vascular ET-1 tissue levels
¨[9] Boulanger C, Luscher TF. Release of endothelin from the porcinecomparable to levels found in C57BL/6J control mice.
aorta: Inhibition by endothelium-derived nitric oxide. J Clin Invest
Lerman et al. reported a strong correlation between ET-1 1990;85:587–590.
immunoreactivity in the coronary and systemic circulation ¨[10] Dohi Y, Luscher TF. Aging differentially affects direct and indirect
actions of endothelin-1 in perfused mesenteric arteries of the rat. Brand the severity of endothelial dysfunction in hypercholes-
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[14] Sellke FW, Armstrong ML, Harrison DG. Endothelium-dependentparticularly if atherosclerosis is already present [14,15,46].
vascular relaxation is abnormal in the coronary microcirculation of
The findings suggest that darusentan normalized enhanced atherosclerotic primates. Circulation 1990;81:1586–1593.
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